IRIS
LIGUORI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.059
AS - Asia 5.349
EU - Europa 3.885
SA - Sud America 732
AF - Africa 106
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 38.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.824
SG - Singapore 2.715
IT - Italia 1.230
CN - Cina 829
BR - Brasile 612
RU - Federazione Russa 531
HK - Hong Kong 416
VN - Vietnam 389
BD - Bangladesh 370
IE - Irlanda 361
DE - Germania 338
UA - Ucraina 261
GB - Regno Unito 253
FR - Francia 246
KR - Corea 172
JP - Giappone 153
FI - Finlandia 150
CA - Canada 149
SE - Svezia 112
NL - Olanda 109
PL - Polonia 78
IN - India 77
ID - Indonesia 56
AR - Argentina 54
AT - Austria 44
ES - Italia 42
MX - Messico 36
ZA - Sudafrica 32
CZ - Repubblica Ceca 27
TR - Turchia 24
EG - Egitto 23
BE - Belgio 22
IQ - Iraq 22
JM - Giamaica 17
CL - Cile 14
MA - Marocco 14
PH - Filippine 13
AU - Australia 12
CO - Colombia 12
MY - Malesia 12
SA - Arabia Saudita 12
CH - Svizzera 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
DK - Danimarca 10
GR - Grecia 10
PY - Paraguay 10
RO - Romania 10
EC - Ecuador 9
VE - Venezuela 9
UZ - Uzbekistan 8
CR - Costa Rica 7
ET - Etiopia 7
EU - Europa 7
KZ - Kazakistan 7
TN - Tunisia 7
AZ - Azerbaigian 6
DZ - Algeria 6
KE - Kenya 6
PE - Perù 6
IL - Israele 5
JO - Giordania 5
LT - Lituania 5
NI - Nicaragua 5
QA - Qatar 5
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
HN - Honduras 4
HU - Ungheria 4
NP - Nepal 4
PT - Portogallo 4
TW - Taiwan 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
HR - Croazia 3
LB - Libano 3
NG - Nigeria 3
SI - Slovenia 3
SV - El Salvador 3
TH - Thailandia 3
BB - Barbados 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BM - Bermuda 1
Totale 38.137
Salva come PNG Salva come JPEG
Città #
Wilmington 6.475
Houston 6.076
Woodbridge 5.585
Singapore 1.108
Ashburn 1.073
Fairfield 978
San Jose 661
Chandler 511
Council Bluffs 442
Seattle 422
Hong Kong 400
Ann Arbor 375
Cambridge 373
Beijing 326
Dublin 318
New York 280
Rome 280
Los Angeles 243
Medford 234
Santa Clara 223
Monte Vista 214
Jacksonville 195
Milan 176
The Dalles 156
Tokyo 126
Ho Chi Minh City 120
Buffalo 112
Lawrence 112
Dearborn 111
Lauterbourg 107
Hanoi 98
Moscow 92
Helsinki 81
Dallas 80
São Paulo 79
San Diego 74
Menlo Park 73
Colorado Springs 65
London 57
Munich 55
Orem 52
Boardman 49
North Bergen 46
Toronto 45
Kraków 44
Zhengzhou 43
Chicago 42
Norwalk 41
Miano 40
Montreal 39
Jakarta 35
Brooklyn 33
Shanghai 33
Atlanta 32
Phoenix 32
Redwood City 32
Denver 31
Stockholm 31
Seoul 29
Manchester 28
Nuremberg 28
Warsaw 28
Amsterdam 26
Boston 26
Frankfurt am Main 26
Philadelphia 24
Brno 23
Chennai 22
Johannesburg 22
Brussels 20
Da Nang 20
Guangzhou 20
Naples 20
Redondo Beach 20
Bologna 19
Columbus 19
Durham 19
Salt Lake City 18
Vienna 18
Washington 17
Istanbul 16
Lappeenranta 16
Miami 16
Nanjing 16
Belo Horizonte 15
Cairo 15
Daejeon 15
Kilburn 15
Rio de Janeiro 15
San Francisco 15
Verona 15
Mexico City 14
Monte Porzio Catone 14
Biên Hòa 12
Florence 12
Haiphong 12
Mumbai 12
Palo Alto 12
Poplar 12
Brasília 11
Totale 30.038
Salva come PNG Salva come JPEG
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 627
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 586
Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions 558
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 519
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 516
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 508
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 496
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 484
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 480
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 477
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 473
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 473
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 463
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 463
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 456
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 454
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 454
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 451
May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis 447
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 443
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 441
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 441
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 440
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 438
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 436
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 433
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 432
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 430
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 430
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 427
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 427
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 422
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 418
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 418
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 414
Catecholamine-based treatment in AD patients: expectations and delusions 412
Restless legs syndrome and post polio syndrome: a case-control study 398
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 397
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 395
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 394
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 393
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 393
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 390
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 390
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 382
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 382
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 372
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report 370
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 369
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 367
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 366
Obstructive sleep apnoea and bone health 356
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 352
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 350
Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity 346
CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease 339
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 324
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 322
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 322
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 300
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 293
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 292
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 289
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study 285
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 282
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 282
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 270
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 261
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 260
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 254
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 252
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 249
Seasonality of restless legs syndrome: symptom variability in winter and summer times 225
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 211
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 201
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 194
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 189
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 189
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 189
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 188
Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment 183
Laterality of Auditory Dysfunction in Parkinson's Disease 179
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 179
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 176
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 175
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 161
Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease 155
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 154
Prognostic Indicators and Outcomes of Hospitalised COVID-19 Patients with Neurological Disease: A Systematic Review and Individual Patient Data Meta-Analysis 154
Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson's disease: a cerebrospinal fluid-based study 146
Is it time to consider obstructive sleep apnea syndrome a risk factor for Alzheimer's disease? 143
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 139
Increased noradrenaline as an additional cerebrospinal fluid biomarker in PSP-like parkinsonism 137
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 134
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 133
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 124
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 123
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy 122
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients 122
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum 119
Totale 33.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.337 54 80 60 33 26 64 229 41 69 104 94 483
2022/20231.438 179 119 49 151 131 324 128 103 127 27 57 43
2023/2024700 72 15 37 26 63 204 35 103 13 21 7 104
2024/20254.115 128 625 319 187 101 482 168 174 336 314 730 551
2025/20268.516 510 265 733 633 562 270 917 827 731 697 1.750 621
2026/2027698 698 0 0 0 0 0 0 0 0 0 0 0
Totale 39.148